peak and trough concentrations after 8 weeks oral therapy with felodipine , a vasodilating calcium antagonist of the dihydropyridine group , were predicted from intravenous pharmacokinetic data before therapy in 11 patients , randomly allocated to felodipine treatment 10 mg b.i.d. , during a placebo controlled study in patients with congestive heart failure .
C0015772
felodipine
C2945601
calcium antagonist